Cited 9 times in 
Cited 9 times in 
Achievement of LDL-C targets defined by ESC/EAS (2011) guidelines in risk-stratified Korean patients with dyslipidemia receiving lipid-modifying treatments
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yang, Ye Seul | - |
| dc.contributor.author | Lee, Seo Young | - |
| dc.contributor.author | Kim, Jung-Sun | - |
| dc.contributor.author | Choi, Kyung Mook | - |
| dc.contributor.author | Lee, Kang Wook | - |
| dc.contributor.author | Lee, Sang-Chol | - |
| dc.contributor.author | Cho, Jung Rae | - |
| dc.contributor.author | Oh, Seung-Jin | - |
| dc.contributor.author | Kim, Ji-Hyun | - |
| dc.contributor.author | Choi, Sung Hee | - |
| dc.date.accessioned | 2021-09-29T02:26:19Z | - |
| dc.date.available | 2021-09-29T02:26:19Z | - |
| dc.date.created | 2021-03-17 | - |
| dc.date.issued | 2020-06 | - |
| dc.identifier.issn | 2093-596X | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/184894 | - |
| dc.description.abstract | Background: This study assessed the proportion of risk-stratified Korean patients with dyslipidemia achieving their low-density lipoprotein cholesterol (LDL-C) targets as defined by the European Society of Cardiology/European Atherosclerosis Society (ESC/ EAS) (2011) guidelines while receiving lipid-modifying treatments (LMTs). Methods: In this multicenter, cross-sectional, observational study, we evaluated data from Korean patients aged ≥19 years who were receiving LMTs for ≥3 months and had an LDL-C value within the previous 12 months on the same LMT. Data were collected for demographics, cardiovascular (CV) risk factors, medical history, and healthcare consumption. Patients were risk-stratified according to the ESC Systematic COronary Risk Evaluation (SCORE) chart and LDL-C target achievement rate was assessed. Results: Guideline-based risk-stratification of the 1,034 patients showed the majority (72.2%) to be in the very high-risk category. Investigators' assessment of risk was underestimated in 71.6% compared to ESC/EAS guidelines. Overall LDL-C target achievement rate was 44.3%; target achievement was the highest (66.0%) in moderate-risk patients and the lowest (39.0%) in very high-risk patients. Overall 97.1% patients were receiving statin therapy, mostly as a single-agent (89.2%). High-intensity statins and the highest permissible dose of high-intensity statins had been prescribed to only 9.1% and 7.3% patients in the very high-risk group, respectively. Physician satisfaction with patients' LDL-C levels was the primary reason for non-intensification of statin therapy. Conclusion: Achievement of target LDL-C level is suboptimal in Korean patients with dyslipidemia, especially in those at very high-risk of CV events. Current practices in LMTs need to be improved based on precise CV risk evaluation posed by dyslipidemia. © 2020 Korean Endocrine Society | - |
| dc.description.statementOfResponsibility | open | - |
| dc.language | English | - |
| dc.publisher | Korean Endocrine Society | - |
| dc.relation.isPartOf | Endocrinology and Metabolism(대한내분비학회지) | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Achievement of LDL-C targets defined by ESC/EAS (2011) guidelines in risk-stratified Korean patients with dyslipidemia receiving lipid-modifying treatments | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | Yang, Ye Seul | - |
| dc.contributor.googleauthor | Lee, Seo Young | - |
| dc.contributor.googleauthor | Kim, Jung-Sun | - |
| dc.contributor.googleauthor | Choi, Kyung Mook | - |
| dc.contributor.googleauthor | Lee, Kang Wook | - |
| dc.contributor.googleauthor | Lee, Sang-Chol | - |
| dc.contributor.googleauthor | Cho, Jung Rae | - |
| dc.contributor.googleauthor | Oh, Seung-Jin | - |
| dc.contributor.googleauthor | Kim, Ji-Hyun | - |
| dc.contributor.googleauthor | Choi, Sung Hee | - |
| dc.identifier.doi | 10.3803/EnM.2020.35.2.367 | - |
| dc.relation.journalcode | J00773 | - |
| dc.identifier.eissn | 2093-5978 | - |
| dc.subject.keyword | Cholesterol | - |
| dc.subject.keyword | Dyslipidemias | - |
| dc.subject.keyword | Hydroxymethylglutaryl-CoA reductase inhibitors | - |
| dc.subject.keyword | Korea | - |
| dc.subject.keyword | LDL | - |
| dc.subject.keyword | Practice guideline | - |
| dc.subject.keyword | Risk assessment | - |
| dc.contributor.alternativeName | Kim, Jung Sun | - |
| dc.contributor.affiliatedAuthor | Kim, Jung-Sun | - |
| dc.identifier.scopusid | 2-s2.0-85089379368 | - |
| dc.identifier.wosid | 000596724000018 | - |
| dc.citation.volume | 35 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | 367 | - |
| dc.citation.endPage | 376 | - |
| dc.identifier.bibliographicCitation | Endocrinology and Metabolism(대한내분비학회지), Vol.35(2) : 367-376, 2020-06 | - |
| dc.identifier.rimsid | 68062 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | Cholesterol | - |
| dc.subject.keywordAuthor | Dyslipidemias | - |
| dc.subject.keywordAuthor | Hydroxymethylglutaryl-CoA reductase inhibitors | - |
| dc.subject.keywordAuthor | Korea | - |
| dc.subject.keywordAuthor | LDL | - |
| dc.subject.keywordAuthor | Practice guideline | - |
| dc.subject.keywordAuthor | Risk assessment | - |
| dc.subject.keywordPlus | antilipemic agent | - |
| dc.subject.keywordPlus | fibric acid derivative | - |
| dc.subject.keywordPlus | hydroxymethylglutaryl coenzyme A reductase inhibitor | - |
| dc.subject.keywordPlus | low density lipoprotein cholesterol | - |
| dc.subject.keywordPlus | omega 3 fatty acid | - |
| dc.subject.keywordPlus | adult | - |
| dc.subject.keywordPlus | Article | - |
| dc.subject.keywordPlus | cardiovascular disease assessment | - |
| dc.subject.keywordPlus | cardiovascular risk | - |
| dc.subject.keywordPlus | cohort analysis | - |
| dc.subject.keywordPlus | controlled study | - |
| dc.subject.keywordPlus | cross-sectional study | - |
| dc.subject.keywordPlus | dyslipidemia | - |
| dc.subject.keywordPlus | female | - |
| dc.subject.keywordPlus | health care utilization | - |
| dc.subject.keywordPlus | high risk population | - |
| dc.subject.keywordPlus | human | - |
| dc.subject.keywordPlus | Korean (people) | - |
| dc.subject.keywordPlus | major clinical study | - |
| dc.subject.keywordPlus | male | - |
| dc.subject.keywordPlus | medical history | - |
| dc.subject.keywordPlus | middle aged | - |
| dc.subject.keywordPlus | observational study | - |
| dc.subject.keywordPlus | physician | - |
| dc.subject.keywordPlus | practice guideline | - |
| dc.subject.keywordPlus | prescription | - |
| dc.subject.keywordPlus | risk assessment | - |
| dc.subject.keywordPlus | systematic coronary risk evaluation | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.